Exchange
—
Entity type
operating
Fiscal year end
Jun 30
Headquarters
DE
Company overview
Lannett Co. Inc. is a specialty pharmaceutical manufacturer best known for generic tablets and capsules, serving hospitals, health systems, chain pharmacies, and pharmacy benefit managers that rely on steady, competitively priced alternatives to branded drugs; its portfolio spans pain relief, cardiovascular, CNS, respiratory, and hormonal therapies built in FDA-approved facilities where ongoing compliance with GMP and evolving regulations shapes every launch. Operating within SIC 2834 (Pharmaceutical Preparations), the company must continuously manage material risks tied to complex supply chains, pricing pressures, and the regulatory scrutiny that accompanies approval and inspection cycles, particularly as new or pending filings demand detailed explanations of safety, effectiveness, and manufacturing controls. While the most recent filing is currently unspecified, the firm’s disclosures remain essential for tracking approval updates, litigation, and working capital trends, especially given the absence of a public ticker symbol. CIK 57725 anchors all of this reporting, so follow along to view live SEC filings on Earnings Feed.
Source: Earnings Feed research · last updated 11/24/2025
Recent filings
- LANNETT CO INC4.0 KB
LANNETT CO INC 8-K
- LANNETT CO INC5.0 KB
LANNETT CO INC 8-K
- LANNETT CO INC52.0 KB
LANNETT CO INC 10-Q